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Introduction {#s1}
============

Although there are currently numerous co-existing clinical scores for critically ill patients \[sequential organ failure assessment (SOFA) [@pone.0109649-Vincent1], Simplified Acute Physiology *Score (SAPS)* [@pone.0109649-Le1], [@pone.0109649-Le2], Acute Physiology and Chronic Health Evaluation (APACHE) [@pone.0109649-Knaus1]--[@pone.0109649-Keegan1]\], none of them has sufficient accuracy to predict outcome. Raising the sensitivity and specificity and increasing the number of parameters in order to enhance statistical power reduce the simplicity and cost effectiveness for clinical use. Given the aging population and numerous cases of co-morbidity in intensive care unit (ICU) setting today, acute kidney injury (AKI) remains a common and serious complication [@pone.0109649-Hoste1]--[@pone.0109649-Hsu1]. Pathophysiological factors associated with AKI are also incriminated in the failure of other organs, indicating that AKI is often part of a multiple organ failure syndrome. The occurrence of individual organ system failures varies among patients admitted to the ICU with AKI, with different degrees of association existing between individual organ system failures and ICU mortality. From this viewpoint, the SOFA score is an excellent tool for assessing the extent of organ dysfunction in critically ill patients with AKI [@pone.0109649-deMendonca1], [@pone.0109649-Lin1]. However, there is no extant literature comparing these scoring systems in the setting of AKI defined by the risk of renal failure, injury to kidney, failure of kidney function, loss of kidney function, and end-stage renal failure (RIFLE) classification in critically ill patients [@pone.0109649-Bellomo1].

We hypothesized that the discriminative power of the SOFA score in predicting ICU mortality is further enhanced for patients with AKI compared to those without. Therefore, we undertook a post hoc analysis of a prospectively accumulated database, to explore 3 ICU mortality scoring systems (SOFA and APACHE II & III) in critically ill patients with/without AKI and to compare the scores in these heterogeneous groups in three ICU admission settings.

Materials and Methods {#s2}
=====================

Study participants and data collection {#s2a}
--------------------------------------

This investigation was carried out at three ICUs of one tertiary-care referral center between July 2007 and June 2008. These ICUs included two medical ICUs and one coronary care unit (CCU). The Chang Gung Memorial Hospital Institutional Review Board approved the study and waived the need of informed consent because there was no breach of privacy and the study did not interfere with clinical decisions related to patient care (approval No. 101-3059B). The patient information was anonymized and de-identified prior to analysis. There were 885 admissions during this period; final diagnosis and admission duration were reviewed first. Patients were excluded if they stayed in the ICU for less than 1 day (n = 89) or had repeated ICU admission (n = 56). Patients under 18 years of age, with organ transplant and end-stage renal disease (ESRD) with long-term dialysis were excluded (n = 154). To determine the ICU outcomes, we also excluded patients admitted to the ICU for observation after invasive procedures (n = 43).

Finally, a total of 543 cases were enrolled in this study. Post hoc analysis of a prospectively accumulated database examined the demographics and clinical characteristics recorded on the first day of ICU admission.

Definitions {#s2b}
-----------

Pertinent medical history included respiratory failure (need for mechanical ventilation), AKI (based on the RIFLE classification), severe upper gastrointestinal (GI) bleeding (defined as massive GI bleeding combined with shock or need of ventilator assistance for procedure), congestive heart failure (CHF, based on Framingham criteria and defined as New York Heart Association functional class IV), hepatic encephalopathy grade II (according to World Congresses of Gastroenterology), shock (defined as hypotension with systolic arterial blood pressure of 90 mm Hg despite adequate fluid resuscitation), severe sepsis (defined as presence of 2 or more systemic inflammatory response syndrome criteria, proven or suspected infection) and associated organ dysfunction (according to modified American College of Chest Physicians and Society of Critical Care Medicine consensus criteria), acute myocardial infarction (AMI, defined according to the 2007 Expert Consensus Document of Circulation from the European Heart Journal), acute respiratory distress syndrome (based on the American-European Consensus Conference), hepatic carcinoma rupture (diagnosed by image and ascites puncture), arrhythmia (defined as ventricular tachycardia, ventricular filtrations, 2- or 3-degree AV block) [@pone.0109649-Bellomo1]--[@pone.0109649-Bernard1]. The worst physiological and biochemical values on the first day of ICU admission were recorded. Neurological scoring was not performed in patients who were paralyzed or sedated since their conditions were not classified as neurological failure. The best verbal response for in-patients who had been intubated but not sedated was determined according to clinical judgment. Illness severity was assessed by the following scoring systems: APACHE II, III and SOFA [@pone.0109649-Vincent1], [@pone.0109649-Knaus1], [@pone.0109649-Knaus2], [@pone.0109649-Knaus3]. The RIFLE was also evaluated at the time of ICU admission. Baseline serum creatinine (SCr) was the first value measured during hospitalization. The modification of diet in renal disease (MDRD) formula was used to estimate the baseline SCr levels in 45 patients because these patients had been admitted directly to the ICU and their previous SCr levels were unknown [@pone.0109649-Bellomo1].

Statistical analysis {#s2c}
--------------------

Continuous variables were summarized by mean and standard error unless otherwise stated. The Kolmogorov-Smirnov test was used to determine the normal distribution for each variable. Student's *t*-test was used to compare the means of continuous variables and normally distributed data; otherwise, the Mann-Whitney U test was used. Categorical data were tested using the Chi-square test or Fisher's exact test. Furthermore, the Hosmer-Lemeshow goodness-of-fit test was used for calibration when evaluating the number of observed and predicted deaths in risk groups for the entire range of death probabilities. Discrimination was assessed using the area under a receiver operating characteristic curve (AUROC), which was compared by a nonparametric approach. The AUROC analysis calculated cutoff values, sensitivity, specificity, and overall correctness. Finally, cutoff points were calculated with acquiring the best Youden index. The index is defined as sensitivity+specificity −1, where sensitivity and specificity are calculated as proportions. Youden index has minimum and maximum values of −1 and +1, respectively, with a value of +1 representing the optimal value for an algorithm. Cumulative survival curves as a function of time were generated by the Kaplan-Meier approach and compared with a log rank test. All statistical tests were two-tailed; a value of *p*\<0.05 was considered statistically significant.

Results {#s3}
=======

Subject characteristics {#s3a}
-----------------------

Five hundred and forty-three critically ill patients admitted to medical ICUs were enrolled. [Table 1](#pone-0109649-t001){ref-type="table"} shows demographic data, clinical characteristics and illness severity of patients with AKI and non-AKI. The median patient age was 62 years. Three hundred and ninety (71.8%) patients were males and 153 (28.2%) were females. Among these patients, one hundred and eighty-seven (34.4%) patients had AKI at ICU admission as determined by the RIFLE classification. Compared to non-AKI patients, the AKI group had a longer ICU stay, low hemoglobin (Hb) (*p*\<0.001), less serum albumin (*p*\<0.001), as well as more hospital and ICU mortality.

10.1371/journal.pone.0109649.t001

###### Demographic data and clinical characteristics according to total v.s. AKI v.s. non-AKI.

![](pone.0109649.t001){#pone-0109649-t001-1}

                                             Total (n = 543)   AKI (n = 187)   Non-AKI (n = 356)   *p*-value   
  ----------------------------------------- ----------------- --------------- ------------------- ------------ --
  Age (years)                                   62.2±0.7         64.1±1.1          61.6±0.9        NS (0.09)   
  Male/Female                                    390/153          130/57            260/96         NS (0.359)  
  Length of ICU stay (days)                     11.7±0.5         13.7±1.0          10.7±0.7          0.009     
  Length of hospital stay (days)                21.5±0.9         22.1±1.6          21.2±1.0        NS (0.60)   
  Body weight on ICU admission (kg)             62.3±0.6         61.4±1.0          62.8±0.8        NS (0.27)   
  GCS, ICU first day (points)                    11±0.2           10±0.3            12±0.2          \<0.001    
  MAP, ICU admission (mmHg)                     77.1±1.7         73.8±1.5          79.7±2.7        NS (0.083)  
  Serum creatinine, ICU first day (mg/dl)        2.1±0.1          3.5±0.2           1.3±0.1         \<0.001    
  Arterial HCO~3~ ^−^, ICU first day            21.7±0.3         19.3±0.5          22.9±0.3         \<0.001    
  Serum sodium, ICU first day (mg/dl)           138.3±0.3        138.0±0.7         138.5±0.4       NS (0.545)  
  Bilirubin, ICU first day (mg/dl)               4.3±0.4          6.6±0.8           3.1±0.3         \<0.001    
  Albumin, ICU first day (g/l)                   2.8±0.1          2.5±0.1           3.0±0.1         \<0.001    
  Blood Sugar, ICU first day (mg/dl)            168.4±4.8       182.1±10.3          161±5.0        NS (0.073)  
  Hemoglobin, ICU first day (g/dl)              10.4±0.1          9.7±0.2          10.8±0.1         \<0.001    
  Platelets, ICU first day (x10^3^/µL)          166.4±4.8        143.4±8.0         178.5±5.9        \<0.001    
  Leukocytes, ICU first day (x10^3^/µL)         10.9±0.3         11.9±0.7           9.7±0.4          0.005     
  PaO~2~/FiO~2~, ICU first day (mmHg)           279.6±6.6       260.2±10.4         289.9±8.3         0.031     
  ICU mortality (%)                            220 (40.5)       116 (62.0)        104 (29.2)        \<0.001    
  Hospital mortality (%)                       243 (44.8)       131 (70.1)        112 (31.5)        \<0.001    
  Need for renal replacement therapy (%)        34 (6.2)         34 (18.1)            --               --      
  *Underlying diseases*                                                                                        
  Diabetes mellitus (%)                        164 (30.2)        67 (35.8)         97 (27.2)         0.044     
  Hypertension (%)                             188 (34.6)        57 (30.4)        131 (36.7)       NS (0.135)  
  Cardiovascular disease (%)                   148 (27.3)        47 (25.1)        101 (28.4)       NS (0.421)  
  Chronic kidney disease (%)                   113 (20.8)        62 (33.1)         51 (14.3)        \<0.001    
  Liver disease (%)                            191 (35.2)        74 (39.6)        117 (32.9)       NS (0.120)  
  Malignancy (%)                               105 (19.3)        35 (18.7)         70 (19.7)       NS (0.791)  
  *Score systems*                                                                                              
  APACHE II, ICU first day (mean ± SE)          18.0±0.4         23.2±0.6          15.2±0.4         \<0.001    
  APACHE III, ICU first day (mean ± SE)         72.4±1.5         94.3±2.3          60.2±1.6         \<0.001    
  SOFA, ICU first day (mean ± SE)                7.4±0.2         10.5±0.3           5.8±0.2         \<0.001    
  RIFLE, ICU first day (mean ± SE)               0.8±0.1          2.0±0.1             --               --      
  RIFLE-R (%)                                   66 (12.2)        66 (35.3)            --               --      
  RIFLE-I (%)                                   54 (9.9)         54 (28.9)            --               --      
  RIFLE-F (%)                                   67 (12.3)        67 (35.8)            --               --      

Abbreviation: AKI, acute kidney injury; NS, not significant; ICU, intensive care unit; SE, standard error; GCS, Glasgow coma scale; MAP, mean arterial pressure; PaO2, arterial partial pressure of oxygen; FiO2, fraction of inspired oxygen; APACHE, Acute Physiology and Chronic Health Evaluation; SOFA, sequential organ failure assessment; RIFLE, risk of renal failure, injury to the kidney, failure of kidney function, loss of kidney function, and end-stage renal failure.

[Table 2](#pone-0109649-t002){ref-type="table"} shows the demographic data and scoring systems of ICU survivors and non-survivors. In the non-survival group of the total population, these patients had longer ICU stays but fewer hospital days. In addition, low Hb (*p*\<0.001) and serum albumin (*p*\<0.001) were also noted in these patients. Moreover, the non-AKI ICU non-survival patients still had a significantly longer ICU stay but fewer hospital days. They also had very significantly lower Hb (*p*\<0.001) and serum albumin (*p*\<0.001) on ICU day 1. After adjusting the SOFA score in the multivariate analysis, the Hb and serum albumin still reached a significant difference (*p*\<0.05) for those non-AKI patients. Furthermore, the AKI ICU non-survival patients had significantly fewer hospital days but not significantly shorter ICU stay. They also tended to have low Hb (*p* = 0.022) and serum albumin (*p* = 0.014) on the first day of ICU admission. However, the Hb and serum albumin were not found to be significantly different for these AKI patients after adjusting the SOFA score in the multiple logistic regression.

10.1371/journal.pone.0109649.t002

###### Demographic data and clinical characteristics of total population, non-AKI and AKI groups according to ICU mortality.
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                                               Total                 Non-AKI group               AKI group                                          
  ----------------------------------------- ----------- ----------- --------------- ----------- ------------ ------------ ------------ ------------ ------------
  Age (years)                                62.8±0.9    62.1±1.0     NS (0.616)     60.4±1.7     62.1±1.0    NS (0.396)    65.8±1.8     62.9±1.4    NS (0.223)
  Male/Female                                 218/82      172/71      NS (0.802)      194/72       66/24      NS (0.981)     52/19        78/38      NS (0.387)
  Length of ICU stay (days)                   8.4±0.6    15.8±0.9       \<0.001       8.7±0.7     16.7±1.6     \<0.001      12.3±1.3     14.6±1.3    NS (0.241)
  Length of hospital stay (days)             23.4±1.2    19.2±1.2        0.016       22.5±1.3     17.3±1.6      0.012       34.3±2.9     14.7±1.3     \<0.001
  Body weight on ICU admission (kg)          63.3±0.8    61.0±0.9     NS (0.055)     63.9±0.9     59.5±1.4      0.011       60.8±1.5     61.7±1.3    NS (0.666)
  GCS, ICU first day (points)                12.7±0.2     9.9±0.3       \<0.001      12.7±0.3     10.8±0.5      0.001       11.9±0.5     8.9±0.5      \<0.001
  MAP, ICU admission (mmHg)                  80.1±3.8    75.1±1.4     NS (0.170)     81.7±4.3     76.1±2.4    NS (0.370)    80.5±2.7     71.3±1.8      0.008
  Serum creatinine, ICU first day (mg/dl)     1.7±0.1     2.5±0.1       \<0.001       1.7±0.1     1.8±0.2     NS (0.444)    2.9±0.6      2.7±0.4     NS (0.765)
  Arterial HCO~3~ ^−^, ICU first day         22.8±0.4    20.2±0.4       \<0.001      23.1±0.4     22.1±0.7    NS (0.220)    20.6±0.8     18.5±0.6      0.021
  Bilirubin, ICU first day (mg/dl)            1.8±0.2     7.4±0.7       \<0.001       2.3±0.3     5.2±0.8       0.001       2.1±0.6      9.3±1.1      \<0.001
  Albumin, ICU first day (g/l)                3.1±0.1     2.5±0.1       \<0.001       3.2±0.1     2.5±0.1      \<0.001      2.6±0.6      2.4±0.4       0.014
  Hemoglobin, ICU first day (g/dl)           11.1±0.2     9.6±0.1       \<0.001      11.2±0.2     9.7±0.3      \<0.001      10.2±0.3     9.4±0.2       0.022
  Platelets, ICU first day (x10^3^/µL)       186.8±6.1   141.7±7.4      \<0.001      185.8±6.2   157.6±16.7   NS (0.077)   178.1±13.5   122.1±9.4      0.001
  PaO~2~/FiO~2~, ICU first day (mmHg)        301.5±8.6   252.4±9.9      \<0.001      308.2±9.3   233.9±16.7    \<0.001     283.5±16.7   246.5±13.2   NS (0.086)
  *Score systems*                                                                                                                                   
  APACHE II, ICU first day (mean ± SE)       14.5±0.4    23.8±0.5       \<0.001      13.0±0.4     21.0±0.7     \<0.001      19.1±0.8     25.9±0.7     \<0.001
  APACHE III, ICU first day (mean ± SE)      54.3±1.5    94.1±1.9       \<0.001      54.5±1.6     82.2±2.9     \<0.001      75.5±2.6    106.6±2.8     \<0.001
  SOFA, ICU first day (mean ± SE)             5.3±0.2    10.1±0.3       \<0.001       5.0±0.2     8.2±0.4      \<0.001      7.7±0.4      12.2±0.3     \<0.001
  RIFLE, ICU first day (mean ± SE)            0.5±0.1     1.4±0.1       \<0.001         --           --           --        1.5±0.1      2.3±0.1      \<0.001

Abbreviation: AKI, acute kidney injury; NS, not significant; ICU, intensive care unit; SE, standard error; GCS, Glasgow coma scale; MAP, mean arterial pressure; PaO2, arterial partial pressure of oxygen; FiO2, fraction of inspired oxygen; APACHE, Acute Physiology and Chronic Health Evaluation; SOFA, sequential organ failure assessment.

The reasons for admission to the ICU are listed in [Table 3](#pone-0109649-t003){ref-type="table"}. The major causes of ICU admission were respiratory failure (58%) and severe UGI bleeding (21.7%). The causes of AKI are listed in [Table 4](#pone-0109649-t004){ref-type="table"}. The major causes of AKI are sepsis (34.2%), acute respiratory distress syndrome (ARDS) (17.1%) and hypovolemic shock (12.8%).

10.1371/journal.pone.0109649.t003

###### Causes of ICU admission.

![](pone.0109649.t003){#pone-0109649-t003-3}

                                            All patients n (%)   Survivors n (%)   Non-survivors n (%)      *p*
  ---------------------------------------- -------------------- ----------------- --------------------- ------------
  Respiratory failure                           315 (58.0)         152 (45.1)          163 (79.1)         \<0.001
  Cirrhosis with severe UGI bleeding            118 (21.7)          57 (16.9)           61 (29.6)         \<0.001
  CHF functional class IV                       113 (20.8)          94 (27.9)           19 (9.2)          \<0.001
  Hepatic encephalopathy                        108 (19.9)          42 (12.5)           66 (32.0)         \<0.001
  Shock                                         103 (19.0)         48 (14.72)           55 (26.7)         \<0.001
  Severe sepsis                                 103 (19.0)          33 (9.8)            70 (34.0)         \<0.001
  AMI                                           102 (18.8)          93 (27.6)            9 (4.4)          \<0.001
  ARDS                                          91 (16.8)           41 (12.2)           50 (24.3)         \<0.001
  HCC rupture                                    26 (4.8)           13 (3.9)            13 (6.3)         NS (0.194)
  Arrhythmia                                     22 (4.1)           22 (6.5)              0 (0)           \<0.001
  Others[a](#nt104){ref-type="table-fn"}         22 (4.1)           14 (4.2)             8 (3.9)         NS (0.877)

Abbreviation: ICU, intensive care unit; UGI, upper gastrointestinal; CHF, congestive heart failure; AMI, acute myocardial infarction; ARDS, acute respiratory distress syndrome; HCC, hepatocellular carcinoma; NS, not significant;

Acute pancreatitis severe form, cardiac tamponade, status epilepticus, pulmonary embolism, renal infraction.

10.1371/journal.pone.0109649.t004

###### Causes of AKI.
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                                                  All AKI patients(n = 187)   AKI Survivors(n = 71)   AKI Non-survivors(n = 116)      *p*
  ---------------------------------------------- --------------------------- ----------------------- ---------------------------- ------------
  Sepsis without shock                                    37 (19.8)                 13 (18.3)                 24 (20.7)            NS (0.692)
  Sepsis with shock                                       27 (14.4)                  6 (8.5)                  21 (18.1)            NS (0.068)
  Hypovolemic shock(UGI bleeding, HCC rupture)            24 (12.8)                 12 (16.9)                 12 (10.3)            NS (0.193)
  Decompensated heart failure                             12 (6.4)                  9 (12.7)                   3 (2.6)               0.011
  AMI                                                     15 (8.0)                  11 (15.5)                  4 (3.4)               0.005
  ARDS                                                    32 (17.1)                 10 (14.1)                 22 (19.0)            NS (0.390)
  Hepatorenal syndrome                                    22 (11.8)                  2 (2.8)                  20 (17.2)              0.002
  Contrast induced nephropathy                             9 (4.8)                   5 (7.0)                   4 (3.4)             NS (0.304)
  Others[a](#nt106){ref-type="table-fn"}                   9 (4.8)                   3 (4.2)                   6 (5.2)             NS (1.000)

Abbreviation: AKI, acute kidney injury; NS, not significant; UGI, upper gastrointestinal; HCC, hepatocellular carcinoma; AMI, acute myocardial infarction; ARDS, acute respiratory distress syndrome.

Acute pancreatitis severe form, cardiac tamponade, status epilepticus, pulmonary embolism, renal infraction.

Hospital mortality, short-term prognosis and results of the scoring systems {#s3b}
---------------------------------------------------------------------------

Overall ICU mortality was 37.9% and the hospital mortality was 44.7%. As for the assessment of calibration, [Table 5](#pone-0109649-t005){ref-type="table"} lists goodness-of-fit, as measured by the Hosmer-Lemeshow analysis of predicted ICU mortality risk and the predictive accuracy of the APACHE III and SOFA scores in the different groups. In predicting the ICU mortality, the accuracy of SOFA was as good as that of APACHE III in the AKI group (AUROC: 0.815±0.032). In the non-AKI group, APACHE III was superior to SOFA (AUROC: 0.791±0.027 *vs*. 0.756±0.028). To assess the values of selected cutoff points for predicting ICU mortality, the sensitivity, specificity and overall correctness of prediction were determined ([Table 6](#pone-0109649-t006){ref-type="table"}). The APACHE III scores revealed the best Youden index and highest overall correctness of prediction in both groups. In the AKI group, ICU mortality rates differed significantly (*p*\<0.001) below and above cutoffs for 93 APACHE III points and 10 SOFA points. Cumulative survival rates at 6-month follow-up following hospital discharge differed significantly (*p*\<0.001) for non-AKI vs. AKI groups ([Fig. 1](#pone-0109649-g001){ref-type="fig"}). [Figure 2](#pone-0109649-g002){ref-type="fig"} shows the cumulative rates of survival for patients with coexisting AKI admitted to ICU were dichotomized at 10 SOFA points or less, and more than 11 SOFA points (*p*\<0.001). To evaluate the correlation among APACHE II, APACHE III, SOFA score and various severity of AKI, we compared the means between groups according to the RIFLE classification by using ANOVA. The chi-square for trends revealed that the APACHE II, APACHE III, SOFA score were all significantly different between non-AKI and AKI groups with varying severity (*P*\<0.001) ([Figure 3](#pone-0109649-g003){ref-type="fig"}).

![Comparison of cumulative survival between patients with and without acute kidney injury (AKI) (p\<0.001).](pone.0109649.g001){#pone-0109649-g001}

![Cumulative survival for patients with coexisting AKI admitted to intensive care units were dichotomized at 10 SOFA points or less, and more than 11 SOFA points (p\<0.001).](pone.0109649.g002){#pone-0109649-g002}

![Box plot graph of APACHE II, APACHE III and SOFA score categorized by different AKI severity based on RIFLE classification.\
*P*\<0.001 between groups by one-way analysis of variance (ANOVA).](pone.0109649.g003){#pone-0109649-g003}

10.1371/journal.pone.0109649.t005

###### Calibration and discrimination for the scoring methods in predicting ICU mortality.
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                            Calibration   Discrimination                                       
  ------------------------ ------------- ---------------- ------- ------------- -------------- ------------
  ***Total***                                                                                  
  * APACHE II*                15.362            8          0.052   0.802±0.019    0.764 .839     \<0.001
  * APACHE III*               10.041            8          0.262   0.829±0.018   0.793--0.865    \<0.001
  * SOFA*                      9.870            8          0.274   0.817±0.019   0.780--0.854    \<0.001
  * RIFLE*                     5.690            2          0.058   0.703±0.025   0.655--0.752    \<0.001
  ***AKI group***                                                                              
  ***[AKI total]{.ul}***                                                                       
  * APACHE II*                17.254            8          0.028   0.745±0.037   0.672--0.818    \<0.001
  * APACHE III*                4.800            8          0.779   0.815±0.032   0.752--0.877    \<0.001
  * SOFA*                      7.263            8          0.508   0.815±0.032   0.751--0.878    \<0.001
  * RIFLE*                     3.540            1          0.060   0.772±0.035   0.704--0.893    \<0.001
  ***[RIFLE-R]{.ul}***                                                                         
  * APACHE II*                 3.556            8          0.829   0.737±0.068   0.604--0.870     0.010
  * APACHE III*                7.806            8          0.350   0.830±0.052   0.727--0.933    \<0.001
  * SOFA*                      8.683            8          0.370   0.833±0.050   0.735--0.930    \<0.001
  ***[RIFLE-I]{.ul}***                                                                         
  * APACHE II*                 6.799            8          0.450   0.754±0.068   0.621--0.888     0.002
  * APACHE III*                8.987            8          0.343   0.776±0.070   0.638--0.914     0.005
  * SOFA*                      8.944            8          0.347   0.787±0.069   0.651--0.923     0.003
  ***[RIFLE-F]{.ul}***                                                                         
  * APACHE II*                 5.564            8          0.591   0.704±0.112   0.485--0.923   NS (0.121)
  * APACHE III*                7.952            8          0.438   0.803±0.125   0.558--0.998     0.043
  * SOFA*                      3.602            8          0.824   0.832±0.064   0.707--0.956     0.008
  ***Non-AKI group***                                                                          
  * APACHE II*                 9.280            8          0.319   0.771±0.027   0.719--0.823    \<0.001
  * APACHE III*                8.080            8          0.426   0.791±0.027   0.739--0.843    \<0.001
  * SOFA*                     11.725            8          0.164   0.756±0.028   0.702--0.810    \<0.001

Abbreviation: ICU, intensive care unit; df, degree of freedom; AUROC, areas under the receiver operating characteristic curve; SE, standard error; CI, confidence interval; APACHE, Acute Physiology and Chronic Health Evaluation; SOFA, sequential organ failure assessment; AKI, acute kidney injury; RIFLE, risk of renal failure, injury to the kidney, failure of kidney function, loss of kidney function, and end-stage renal failure.

10.1371/journal.pone.0109649.t006

###### Subsequent ICU mortality predicted after ICU admission.
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  Predictive Factors                 Cutoff Point              Youden Index   Sensitivity (%)   Specificity (%)   Overall Correctness (%)
  ---------------------- ------------------------------------ -------------- ----------------- ----------------- -------------------------
  ***Total***                                                                                                    
  * APACHE II*            20[a](#nt109){ref-type="table-fn"}       0.46             88                56                    72
  * APACHE III*           80[a](#nt109){ref-type="table-fn"}       0.51             70                80                    75
  * SOFA*                 7[a](#nt109){ref-type="table-fn"}        0.48             85                64                    74
  * RIFLE*                R[a](#nt109){ref-type="table-fn"}        0.34             93                34                    64
  ***AKI group***                                                                                                
  * APACHE II*            21[a](#nt109){ref-type="table-fn"}       0.41             75                67                    71
  * APACHE III*           93[a](#nt109){ref-type="table-fn"}       0.49             68                82                    75
  * SOFA*                 10[a](#nt109){ref-type="table-fn"}       0.47             75                73                    74
  * RIFLE*                I[a](#nt109){ref-type="table-fn"}        0.36             78                58                    68
  ***[RIFLE-R]{.ul}***                                                                                           
  * APACHE II*            24[a](#nt109){ref-type="table-fn"}       0.36             53                83                    68
  * APACHE III*           83[a](#nt109){ref-type="table-fn"}       0.56             90                67                    79
  * SOFA*                 11[a](#nt109){ref-type="table-fn"}       0.45             74                67                    71
  ***[RIFLE-I]{.ul}***                                                                                           
  * APACHE II*            19[a](#nt109){ref-type="table-fn"}       0.46             75                71                    73
  * APACHE III*           99[a](#nt109){ref-type="table-fn"}       0.39             43                96                    69
  * SOFA*                 10[a](#nt109){ref-type="table-fn"}       0.44             63                79                    72
  ***[RIFLE-F]{.ul}***                                                                                           
  * APACHE II*            24[a](#nt109){ref-type="table-fn"}       0.36             53                83                    68
  * APACHE III*           83[a](#nt109){ref-type="table-fn"}       0.56             90                67                    79
  * SOFA*                 12[a](#nt109){ref-type="table-fn"}       0.61             67                100                   81
  ***Non-AKI group***                                                                                            
  * APACHE II*            16[a](#nt109){ref-type="table-fn"}       0.44             85                57                    71
  * APACHE III*           52[a](#nt109){ref-type="table-fn"}       0.45             95                49                    72
  * SOFA*                 7[a](#nt109){ref-type="table-fn"}        0.39             69                70                    70

Abbreviation: ICU, intensive care unit; APACHE, Acute Physiology and Chronic Health Evaluation; SOFA, sequential organ failure assessment; AKI, acute kidney injury.

Value giving the best Youden index.

Discussion {#s4}
==========

This post hoc analysis of a prospectively accumulated database study included 543 heterogeneous patients with critical illnesses. The overall in-hospital mortality rate was 44.7%, which is consistent with figures obtained by previous studies indicating poor prognosis of ICU patients with septic shock, ARDS, AKI or hepatic cirrhosis. The occurrence of AKI in this work was 34.4% (187/543) and is in agreement with previous report indicating that the incidence was 35.8% of AKI (defined by the RIFLE classification) in a mixed ICU. The overall AKI group ICU mortality rate observed in this study was 62% (116/187), which was high compared to other studies [@pone.0109649-Hoste1]--[@pone.0109649-deMendonca1], [@pone.0109649-Liu1]. The high mortality may have been attributed to the inclusion of two hundred and fifty-two patients (46.4%) with underlying cirrhosis and ninety-one patients (16.8%) with ARDS, both of which are positively associated with mortality in AKI patients [@pone.0109649-duCheyron1]--. In this study, we demonstrated that SOFA score at ICU day 1 has a comparable predictive ability for ICU mortality to APACHE III in the AKI group (AUROC 0.815 vs. 0.815). On the other hand, the APACHE III was superior to the SOFA score in the non-AKI group (AUROC 0.791 vs.0.756).

Renal failure is common in critically ill patients, and its occurrence is associated with an extremely high mortality rate [@pone.0109649-deMendonca1], [@pone.0109649-Bellomo1], [@pone.0109649-Liu2], [@pone.0109649-Hsu2]. Therefore, outcome prediction for short-term prognosis is needed to identify patients with high mortality risk from AKI. Since ICU patients with AKI is a syndrome and often is precipitated by and co-existing with other organ failure, the SOFA scores performance in evaluating the function of multi-organ systems was found to be as good as those of APACHE III in this work. Beyond the AKI, the mortality in an ICU setting is often related to age and co-existing co-morbidity, thus making the APACHE III score more accurate. When facing AKI patients, assessing the function of other organs is important [@pone.0109649-deMendonca1]. We can simply use the six parameters to predict the outcomes and apply this score to help clinicians to focus their attention on more severe patients. Given that the SOFA score ignores diagnosis, age and co-morbid conditions, this score probably reflects the unique characteristics of the present patient group, whose prognosis can be predicted without considering the factors of age and diagnosis. The influence of age on outcome has been demonstrated to decrease with an increase in disease severity [@pone.0109649-Rockwood1], [@pone.0109649-VanDenNoortgate1]. This can, at least partially, explain why age did not substantially influence the probability of mortality. The mortality rates greatly increased when SOFA scores of 11 or above were recorded in our study, which means that integrating the RIFLE classification and SOFA score, where ≥4 failed/dysfunction organs (including AKI), has fairly poor prognosis. Furthermore, researchers have come a long way in the study of the factors contributing to outcome in AKI patients. At present, the measure of AKI severity can be done using both ICU and specific AKI scores [@pone.0109649-Lin1], [@pone.0109649-Abosaif1]--[@pone.0109649-Chertow1]. Among the current general ICU scores, APACHE III and SOFA scores promise to be very useful. However, because the number and categorization of the variables considered in the APACHE III score is greater, it gains in statistical power but loses in simplicity, and thus the use of APACHE III entails extra cost [@pone.0109649-Chen1].

In the non-AKI critically ill patients group, the discriminatory power of the APACHE III for predicting ICU mortality is superior to that of SOFA score. The non-AKI population in this study admitted to ICU was composed of a high proportion of subjects with AMI, CHF and cirrhosis. Anemia at baseline in patients with AMI undergoing primary percutaneous coronary intervention is common, and is strongly associated with adverse outcomes and increased mortality [@pone.0109649-Anker1]--[@pone.0109649-Hsu3]. In CHF patients, low Hb values directly relate to poor peak oxygen consumption, disabling symptoms, and impaired survival [@pone.0109649-Maraldi1], [@pone.0109649-Groenveld1]. Das *et* *al*. retrospectively evaluated the outcomes of 138 ICU cirrhotic patients and identified the independent risk factors for in hospital mortality as age, albuminemia, international normalized ratio and the SOFA score computed after discarding points for hematologic failure [@pone.0109649-Das1]. As responses to chronic disease, causes cachexia and malnutrition (low Hb and albumin) as well as a systemic inflammation. A lack of Hb and serum albumin prognostic factors in the SOFA score may account for its discriminative inferiority to APACHE III.

Despite the promising analytical results of this study, several important limitations should be recognized. First, this study was conducted at a single institution; consequently, the results may not be directly extrapolated to other patient populations. Second, scoring was performed only on the first day of ICU admission. Sequential application of these scoring systems (for example, daily or weekly) may reflect the dynamic aspects of clinical diseases and thus provide more complete data for mortality risk. Third, the patient population was heterogeneous and contained a high proportion of AMI, CHF, ARDS and cirrhotic patients, and may be viewed as a special subgroup of critically ill patients. Further validation in other cohorts with a multicenter study may be required in the future research. Finally, use of the prognostic instruments in patients already admitted to ICUs rather than as a preadmission screening tool may have skewed measurement results.

Various novel biomarkers such as NGAL (Neutrophil gelatinase-associated lipocalin), KIM-1 (Kidney Injury Molecule-1), interleukin-18 and cystatin C have been developed to assist early diagnosis, differential diagnosis and prognostic prediction in patients with AKI [@pone.0109649-Chen2], [@pone.0109649-Han1]. Combination of biomarkers and traditional scoring systems may further improve the sensitivity, specificity of clinical diagnosis and prognostic prediction, and remained to be clarified in the future.

Conclusions {#s5}
===========

In conclusion, this investigation demonstrated that the prognosis for AKI patients admitted to ICU is poor. The analytic data also highlighted the good discriminative power of the SOFA score in predicting ICU mortality of critically ill patients with AKI defined by RIFLE classification. Considering the economy and ease of implementation, we suggest that SOFA score can increase the accuracy of short-term prognosis in this heterogeneous group of patients.
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